BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 9115367)

  • 1. Triple helix formation with purine-rich phosphorothioate-containing oligonucleotides covalently linked to an acridine derivative.
    Lacoste J; François JC; Hélène C
    Nucleic Acids Res; 1997 May; 25(10):1991-8. PubMed ID: 9115367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triplex formation with alpha anomers of purine-rich and pyrimidine-rich oligodeoxynucleotides.
    Noonberg SB; François JC; Praseuth D; Guieysse-Peugeot AL; Lacoste J; Garestier T; Hélène C
    Nucleic Acids Res; 1995 Oct; 23(20):4042-9. PubMed ID: 7479062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of competing self-structure on triplex formation with purine-rich oligodeoxynucleotides containing GA repeats.
    Noonberg SB; François JC; Garestier T; Hélène C
    Nucleic Acids Res; 1995 Jun; 23(11):1956-63. PubMed ID: 7596824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNase I footprinting of triple helix formation at polypurine tracts by acridine-linked oligopyrimidines: stringency, structural changes and interaction with minor groove binding ligands.
    Stonehouse TJ; Fox KR
    Biochim Biophys Acta; 1994 Aug; 1218(3):322-30. PubMed ID: 8049258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyamine effects on purine-purine-pyrimidine triple helix formation by phosphodiester and phosphorothioate oligodeoxyribonucleotides.
    Musso M; Van Dyke MW
    Nucleic Acids Res; 1995 Jun; 23(12):2320-7. PubMed ID: 7610062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA triple helix formation at target sites containing several pyrimidine interruptions: stabilization by protonated cytosine or 5-(1-propargylamino)dU.
    Gowers DM; Bijapur J; Brown T; Fox KR
    Biochemistry; 1999 Oct; 38(41):13747-58. PubMed ID: 10521282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple helix formation by (G,A)-containing oligonucleotides: asymmetric sequence effect.
    Arimondo PB; Barcelo F; Sun JS; Maurizot JC; Garestier T; Hélène C
    Biochemistry; 1998 Nov; 37(47):16627-35. PubMed ID: 9843430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a triplex-binding ligand on parallel and antiparallel DNA triple helices using short unmodified and acridine-linked oligonucleotides.
    Cassidy SA; Strekowski L; Wilson WD; Fox KR
    Biochemistry; 1994 Dec; 33(51):15338-47. PubMed ID: 7803397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energetics of strand-displacement reactions in triple helices: a spectroscopic study.
    Mills M; Arimondo PB; Lacroix L; Garestier T; Hélène C; Klump H; Mergny JL
    J Mol Biol; 1999 Sep; 291(5):1035-54. PubMed ID: 10518941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodeoxyribonucleotide length and sequence effects on intermolecular purine-purine-pyrimidine triple-helix formation.
    Cheng AJ; Van Dyke MW
    Nucleic Acids Res; 1994 Nov; 22(22):4742-7. PubMed ID: 7984426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor polycyclic acridines. Part 16. Triplex DNA as a target for DNA-binding polycyclic acridine derivatives.
    Missailidis S; Modi C; Trapani V; Laughton CA; Stevens MF
    Oncol Res; 2005; 15(2):95-105. PubMed ID: 16119007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages.
    Cogoi S; Rapozzi V; Quadrifoglio F; Xodo L
    Biochemistry; 2001 Feb; 40(5):1135-43. PubMed ID: 11170438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of the range of DNA sequences available for triple helix formation: stabilization of mismatched triplexes by acridine-containing oligonucleotides.
    Kukreti S; Sun JS; Garestier T; Hélène C
    Nucleic Acids Res; 1997 Nov; 25(21):4264-70. PubMed ID: 9336456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of third strand composition on the triple helix formation: purine versus pyrimidine oligodeoxynucleotides.
    Faucon B; Mergny JL; Héléne C
    Nucleic Acids Res; 1996 Aug; 24(16):3181-8. PubMed ID: 8774898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of a purine.purine.pyrimidine DNA triplex containing G.GC and T.AT triples.
    Radhakrishnan I; Patel DJ
    Structure; 1993 Oct; 1(2):135-52. PubMed ID: 8069626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cations on purine.purine.pyrimidine triple helix formation in mixed-valence salt solutions.
    Floris R; Scaggiante B; Manzini G; Quadrifoglio F; Xodo LE
    Eur J Biochem; 1999 Mar; 260(3):801-9. PubMed ID: 10103010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular dichroism and UV melting studies on formation of an intramolecular triplex containing parallel T*A:T and G*G:C triplets: netropsin complexation with the triplex.
    Gondeau C; Maurizot JC; Durand M
    Nucleic Acids Res; 1998 Nov; 26(21):4996-5003. PubMed ID: 9776765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorothioate oligonucleotide-directed triple helix formation.
    Hacia JG; Wold BJ; Dervan PB
    Biochemistry; 1994 May; 33(18):5367-9. PubMed ID: 8180158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific intercalation at the triplex-duplex junction induces a conformational change which is detectable by hypersensitivity to diethylpyrocarbonate.
    Collier DA; Mergny JL; Thuong NT; Helene C
    Nucleic Acids Res; 1991 Aug; 19(15):4219-24. PubMed ID: 1870975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promotor.
    Svinarchuk F; Debin A; Bertrand JR; Malvy C
    Nucleic Acids Res; 1996 Jan; 24(2):295-302. PubMed ID: 8628653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.